WANJIA GROUP HOLDINGS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.063 HKD | 0.00% |
|
0.00% | -25.88% |
| 2023 | Wanjia Group Holdings Incurs Wider Loss in Fiscal H1 | MT |
| 2023 | Wanjia Group Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Wanjia Group Holdings Ltd is an investment holding company principally engaged in the pharmaceutical wholesale and distribution business, and hemodialysis treatment and consultancy service business. The Company mainly operates its business through two segments. The Pharmaceutical Wholesale and Distribution Business segment mainly distributes pharmaceutical products for pharmaceutical retail chain stores, independent pharmacies and outpatient departments of community hospitals and healthcare service stations. The Hemodialysis Treatment and Consultancy Service Business segment mainly provides kidney care services and operates hemodialysis treatment centers.
Calendar
2024-06-23
- Q4 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -25.88% | 4.51M | |
| -14.92% | 84.68B | |
| +13.30% | 81.12B | |
| +10.92% | 29.4B | |
| -12.71% | 16.73B | |
| -3.06% | 16.36B | |
| -2.63% | 14.92B | |
| -31.75% | 11.77B | |
| -1.42% | 11.72B | |
| +27.44% | 11.71B |
- Stock Market
- Equities
- 401 Stock
- News Wanjia Group Holdings Limited
- Wanjia Group Swings to Profit in FY23 on Higher Revenue
